← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Scott And White Memorial Hospital
Temple, TX
$33,212,752
Total funding
31
Grants
Funding over time
peak $3.4M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$18,487,695 · 25
CDC$14,050,365 · 3
AHRQ$674,692 · 3
By mechanism
U01$14,050,365 · 3
R01$7,051,995 · 11
U10$6,520,455 · 2
K08$1,464,943 · 2
K01$1,309,707 · 4
RC4$994,705 · 1
Investigators at Scott And White Memorial Hospital
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
Mandatory_Estimates of Vaccine Effectiveness Against Medically-Attended, PCR-Confirmed Influenza in West South Central U.S.$1,800,000
U01 · FY2020 · IP
Mandatory_Estimates of Vaccine Effectiveness Against Medically-Attended, PCR-Confirmed Influenza in West South Central U.S.$1,300,000
U01 · FY2018 · IP
Mandatory_Estimates of Vaccine Effectiveness Against Medically-Attended, PCR-Confirmed Influenza in West South Central U.S.$1,300,000
U01 · FY2019 · IP
Community Research Center for Senior Health$994,705
RC4 · FY2010 · AG
Core_RT-PCR based Case-Control: Apt Measure of Influenza Vaccine Effectiveness$945,000
U01 · FY2014 · IP
Core_RT-PCR based Case-Control: Apt Measure of Influenza Vaccine Effectiveness$801,316
U01 · FY2015 · IP
Mandatory_Estimates of Vaccine Effectiveness Against Medically-Attended, PCR-Confirmed Influenza in West South Central U.S.$800,000
U01 · FY2017 · IP
Mandatory_Estimates of Vaccine Effectiveness Against Medically-Attended, PCR-Confirmed Influenza in West South Central U.S.$800,000
U01 · FY2016 · IP
Core_RT-PCR based Case-Control: Apt Measure of Influenza Vaccine Effectiveness$785,000
U01 · FY2012 · IP
Core_RT-PCR based Case-Control: Apt Measure of Influenza Vaccine Effectiveness$785,000
U01 · FY2013 · IP
Core_Apt Measure of PCR-based Influenza Vaccine Effectiveness in Inpatient Adults$700,000
U01 · FY2019 · IP
Core_Apt Measure of PCR-based Influenza Vaccine Effectiveness in Inpatient Adults$700,000
U01 · FY2018 · IP
Core_RT-PCR based Case-Control: Apt Measure of Influenza Vaccine Effectiveness$695,079
U01 · FY2011 · IP
Scott & White Community Clinical Oncology Program$648,992
U10 · FY2008 · CA
Scott & White Community Clinical Oncology Program$537,993
U10 · FY2012 · CA
SCOTT AND WHITE COMMUNITY CLINICAL ONCOLOGY PROGRAM$518,073
U10 · FY2001 · CA
Scott and White Community Clinical Oncology Program$503,763
U10 · FY2007 · CA
Scott & White Community Clinical Oncology Program$502,117
U10 · FY2010 · CA
Mandatory_Estimates of Vaccine Effectiveness Against Medically-Attended, PCR-Confirmed Influenza in West South Central U.S.$500,000
U01 · FY2019 · IP
Core_Apt Measure of PCR-based Influenza Vaccine Effectiveness in Inpatient Adults$500,000
U01 · FY2019 · IP